Literature DB >> 34528077

Targeting the Hippo pathway in heart repair.

Fansen Meng1, Bing Xie1, James F Martin1,2.   

Abstract

The Hippo pathway is an evolutionarily and functionally conserved signalling pathway that controls organ size by regulating cell proliferation, apoptosis, and differentiation. Emerging evidence has shown that the Hippo pathway plays critical roles in cardiac development, homeostasis, disease, and regeneration. Targeting the Hippo pathway has tremendous potential as a therapeutic strategy for treating intractable cardiovascular diseases, such as heart failure. In this review, we summarize the function of the Hippo pathway in the heart. Particularly, we highlight the post-translational modification of Hippo pathway components, including the core kinases LATS1/2 and their downstream effectors YAP/TAZ, in different contexts, which has provided new insights and avenues in cardiac research. Published on behalf of the European Society of Cardiology. All rights reserved.
© The Author(s) 2021. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  Heart development; Heart diseases; Hippo pathway; LATS1/2; Post-translational modification; YAP/TAZ

Mesh:

Year:  2022        PMID: 34528077      PMCID: PMC9400419          DOI: 10.1093/cvr/cvab291

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   13.081


  147 in total

1.  mTORC2 regulates cardiac response to stress by inhibiting MST1.

Authors:  Sebastiano Sciarretta; Peiyong Zhai; Yasuhiro Maejima; Dominic P Del Re; Narayani Nagarajan; Derek Yee; Tong Liu; Mark A Magnuson; Massimo Volpe; Giacomo Frati; Hong Li; Junichi Sadoshima
Journal:  Cell Rep       Date:  2015-04-02       Impact factor: 9.423

2.  A gp130-Src-YAP module links inflammation to epithelial regeneration.

Authors:  Koji Taniguchi; Li-Wha Wu; Sergei I Grivennikov; Petrus R de Jong; Ian Lian; Fa-Xing Yu; Kepeng Wang; Samuel B Ho; Brigid S Boland; John T Chang; William J Sandborn; Gary Hardiman; Eyal Raz; Yoshihiko Maehara; Akihiko Yoshimura; Jessica Zucman-Rossi; Kun-Liang Guan; Michael Karin
Journal:  Nature       Date:  2015-02-25       Impact factor: 49.962

3.  The extracellular matrix protein agrin promotes heart regeneration in mice.

Authors:  Elad Bassat; Yara Eid Mutlak; Alex Genzelinakh; Ilya Y Shadrin; Kfir Baruch Umansky; Oren Yifa; David Kain; Dana Rajchman; John Leach; Daria Riabov Bassat; Yael Udi; Rachel Sarig; Irit Sagi; James F Martin; Nenad Bursac; Shenhav Cohen; Eldad Tzahor
Journal:  Nature       Date:  2017-06-05       Impact factor: 49.962

4.  Hippo promotes proliferation arrest and apoptosis in the Salvador/Warts pathway.

Authors:  Ryan S Udan; Madhuri Kango-Singh; Riitta Nolo; Chunyao Tao; Georg Halder
Journal:  Nat Cell Biol       Date:  2003-09-21       Impact factor: 28.824

5.  Negative regulation of the Hippo pathway by E3 ubiquitin ligase ITCH is sufficient to promote tumorigenicity.

Authors:  Zaidoun Salah; Gerry Melino; Rami I Aqeilan
Journal:  Cancer Res       Date:  2011-01-06       Impact factor: 12.701

6.  Hippo signaling impedes adult heart regeneration.

Authors:  Todd Heallen; Yuka Morikawa; John Leach; Ge Tao; James T Willerson; Randy L Johnson; James F Martin
Journal:  Development       Date:  2013-12       Impact factor: 6.868

7.  gp130 Controls Cardiomyocyte Proliferation and Heart Regeneration.

Authors:  Yandong Li; Jie Feng; Shen Song; Haotong Li; Huijun Yang; Bin Zhou; Yan Li; Zhang Yue; Hong Lian; Lihui Liu; Shengshou Hu; Yu Nie
Journal:  Circulation       Date:  2020-06-30       Impact factor: 29.690

8.  MAP4K family kinases act in parallel to MST1/2 to activate LATS1/2 in the Hippo pathway.

Authors:  Zhipeng Meng; Toshiro Moroishi; Violaine Mottier-Pavie; Steven W Plouffe; Carsten G Hansen; Audrey W Hong; Hyun Woo Park; Jung-Soon Mo; Wenqi Lu; Shicong Lu; Fabian Flores; Fa-Xing Yu; Georg Halder; Kun-Liang Guan
Journal:  Nat Commun       Date:  2015-10-05       Impact factor: 14.919

9.  SKP2- and OTUD1-regulated non-proteolytic ubiquitination of YAP promotes YAP nuclear localization and activity.

Authors:  Fan Yao; Zhicheng Zhou; Jongchan Kim; Qinglei Hang; Zhenna Xiao; Baochau N Ton; Liang Chang; Na Liu; Liyong Zeng; Wenqi Wang; Yumeng Wang; Peijing Zhang; Xiaoyu Hu; Xiaohua Su; Han Liang; Yutong Sun; Li Ma
Journal:  Nat Commun       Date:  2018-06-11       Impact factor: 14.919

10.  Blockade of Fibroblast YAP Attenuates Cardiac Fibrosis and Dysfunction Through MRTF-A Inhibition.

Authors:  Jamie Francisco; Yu Zhang; Jae Im Jeong; Wataru Mizushima; Shohei Ikeda; Andreas Ivessa; Shinichi Oka; Peiyong Zhai; Michelle D Tallquist; Dominic P Del Re
Journal:  JACC Basic Transl Sci       Date:  2020-09-28
View more
  3 in total

Review 1.  Measuring cardiomyocyte cell-cycle activity and proliferation in the age of heart regeneration.

Authors:  John Auchampach; Lu Han; Guo N Huang; Bernhard Kühn; John W Lough; Caitlin C O'Meara; Alexander Y Payumo; Nadia A Rosenthal; Henry M Sucov; Katherine E Yutzey; Michaela Patterson
Journal:  Am J Physiol Heart Circ Physiol       Date:  2022-02-18       Impact factor: 4.733

2.  Integrated Analysis of lncRNA and mRNA Expression Profiles Indicates Age-Related Changes in Meniscus.

Authors:  Li-Ya Ai; Ming-Ze Du; You-Rong Chen; Peng-Yan Xia; Ji-Ying Zhang; Dong Jiang
Journal:  Front Cell Dev Biol       Date:  2022-03-10

3.  YAP Activates STAT3 Signalling to Promote Colonic Epithelial Cell Proliferation in DSS-Induced Colitis and Colitis Associated Cancer.

Authors:  Feihong Deng; Zengrong Wu; Mengmeng Xu; Pianpian Xia
Journal:  J Inflamm Res       Date:  2022-09-19
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.